Research Article | Open Access
Stephen Paul Fitzgerald, Nigel Geoffrey Bean, "The Relationship between Population T4/TSH Set Point Data and T4/TSH Physiology", Journal of Thyroid Research, vol. 2016, Article ID 6351473, 7 pages, 2016. https://doi.org/10.1155/2016/6351473
The Relationship between Population T4/TSH Set Point Data and T4/TSH Physiology
Context. Population studies of the distribution of T4/TSH set points suggest a more complex inverse relationship between T4 and TSH than that suggested by physiological studies. The reasons for the similarities and differences between the curves describing these relationships are unresolved. Methods. We subjected the curve, derived from empiric data, describing the TSH suppression response to T4, and the more mathematically derived curve describing the T4 response to TSH, to the different possible models of population variation. The implied consequences of these in terms of generating a population distribution of T4/TSH equilibrium points (a “population curve”) were generated and compared to the empiric population curve. The physiological responses to primary hypothyroidism and hyperthyroidism were incorporated into the analysis. Conclusions. Though the population curve shows a similarly inverse relationship, it is describing a different relationship than the curve describing the suppression of TSH by T4. The population curve is consistent with the physiological studies of the TSH response to T4 and implies a greater interindividual variation in the positive thyroid T4 response to TSH than in the central inhibitory TSH response to T4. The population curve in the dysthyroid states is consistent with known physiological responses to these states.
There has been debate in the literature as to the reconciliation of the relationships between T4 and TSH. Whilst the curve describing the suppression of TSH by circulating T4 as studied in individuals (the “TSH curve”) is negative log-linear [1–3], population distributions of set point T4/TSH levels in multiple individuals (“the population curve”) have suggested a somewhat similar but more complex negative relationship (Figures 1 and 2(a)) [4, 5]. The TSH curve has been determined by T4 dosing studies whereby TSH levels were measured in individuals at different levels of T4 [1–3]. The population curve is cross-sectional and results from the plotting of simultaneous T4 and TSH (the set point) measurements of a large number of individuals [4, 5].
(a) TSH response to free T4
(b) Free T4 response to TSH
(c) Free T4 response to TSH
(d) Free T4/TSH set point
In particular the curves differ in that the population curve is flatter at the extremes but otherwise has increased slope in the hypothyroid and hyperthyroid ranges . The flattening at the extremes has been attributed to the limits of physiological responses [4, 6]; the other differences between the curves remain unresolved.
Different explanations invoking different artefacts of measurement and population have been offered for the discrepancies between the above curves [4, 5]. It has been suggested that the population curve indicates that the negative log-linear relationship is incomplete or erroneous [4, 5, 7], and more complicated models of thyroid regulation have been suggested [7–10].
The reciprocal physiological T4/TSH relationship, the transmission of TSH to T4, whereby circulating TSH stimulates T4 levels (the “T4 curve”), is more difficult to define experimentally. Its general properties have been confirmed experimentally [11–13] and clinically  and on the basis of these data and pharmacological principles  have been defined mathematically (Figures 2(b) and 2(c)) [7, 16]. We term the TSH and T4 curves the “physiological curves.” Though individual set points have been recognised to be situated at the intersection of the two physiological curves [7, 16] (Figure 2(d)), the formulation of any relationship between the population curve and interindividual variations in these two curves has not been pursued.
The aim of this study was to reconcile the general slope of the population curve with the physiological curves by considering the effects of interindividual variations in these physiological curves. Furthermore we sought to explain the curvature of the population curve in terms of changes to the physiological curves due to previously described physiological responses to primary hypo- and hyperthyroidism.
No new empiric data were generated. In describing the T4/TSH relationships we considered T4 and FT4 to be interchangeable terms describing free T4. We considered pituitary function to include hypothalamic physiology.
We relied on the empiric data already available from the literature for the population curve (Figure 1) and the TSH curve (Figures 1 and 2(a)). Benhadi et al.’s  line of best fit for the TSH curve, typical for this relationship, is described by the formula . The line of best fit for the population curve has been described in at least two ways. Hoermann et al.  considered the curve was best described in terms of response varying in relation to the “error” function, that is, the disturbance in T4 away from an optimum value. Their formula was , where is the error function. In the T4 range 12–16 this resulted in a line not dissimilar to . Hadlow et al.  considered the curve to be a composite of two sigmoid curves. For free T4 concentrations ≤12 the relationship was ; for free T4 concentrations >12 it was .
We used the thyroid transfer characteristic (the “T4 curve”) (Figures 2(b) and 2(c)) as described by Dietrich et al.  and Goede et al. . Goede et al.  have indicated that this relationship is described by the formula pmol/L. represents the maximum T4 yield, and represents the damping constant (EC50) of TSH at the thyroid gland, that is, the concentration of TSH that gives half-maximal T4 response. This formula is “based on Michaelis-Menten kinetics as they are well grounded in physiological and biochemical grounds…” .
We continued the line of this previous work [7, 16] by considering that different individuals, by virtue of differing organ size, and/or differences in any of a myriad of thyroid physiological processes (e.g., circulating T3 level and intrapituitary deiodination), will have greater or lesser increases in T4 secondary to TSH stimulation and analogously greater or lesser TSH suppression by T4. These variations result in different individuals having different T4 and TSH curves.
The T4/TSH equilibrium point was represented by the intersection of the physiological curves as described by Dietrich et al.  and Goede et al.  (Figure 2(d)). Dietrich et al.  indicated a set point lying on the intersection of the two 50th centile curves but we extended this model to indicate that a range of set points is generated by the intersection points of each individual’s two curves. This range of set points in the population is thus the basis of the population curve (Figure 3).
We generated graphs to describe different possible population curves as generated by the possible different patterns of interindividual variation in the two physiological curves, that is, variation in the TSH curve being greater than, less than, or equal to variation in the T4 curve.
We compared the general slope of our resulting curves with that of the published empirically derived population curve.
We also factored into our graphs the previously documented physiological changes to the pituitary in the contexts of primary hypo- and hyperthyroidism to determine whether these physiological changes generated curvatures consistent with those in the published empiric curve.
Figure 4(a) shows how the population curve would appear if there were relatively little or no population variations in the TSH curve but there was a large variation in the T4 curve; it would resemble the TSH curve (a negative slope). In these circumstances interindividual T4 level variation is predominantly determined by the T4 curves.
(a) Variation in the T4 curves
(b) Variation in the TSH curves
(c) Variation in both the T4 and TSH curves
Figure 4(b) shows how the population curve would appear if conversely there were relatively little or no population variations in the T4 curve but there was a large variation in the TSH curve, and thereby the predominant determinant of the T4 level variation is the individual TSH curves (a positive slope).
Figure 4(c) shows how the population curve would appear if there were equal variations in both pituitary and thyroid sensitivities (no strong relationship). In this latter circumstance the TSH and T4 curves would contribute equally to the interindividual variation of the T4 level.
These relationships are as described above under the assumption that the physiological curves of all individuals are independent of each other. In the population context of multiple physiological T4 and TSH curves the population curve would also depend on associations between the two physiological curves. If, for example, some aspects of physiology or natural selection led to nonrandom/nonproportional associations of the physiological curves, the slope of the line of best fit of the population curve might lie anywhere within the bounds of the population variations of the physiological curves or a strong relationship may arise where, in the context of independent curves, there was not any (Figure 5).
Thus the general slope of the population curve may resemble any of the curves of Figure 4 depending on the nature of the interindividual variation in each of the physiological curves. It follows that the population curve cannot of itself describe the nature of the TSH curve and in particular cannot deny the evidence of studies of the physiology of individuals.
Given that in having a negative slope the empirically derived population curve (Figure 1) resembles Figure 4(a), or perhaps Figure 5 in part of the normal range, one can deduce from all the above that the negative slope of the population curve results from the greater variation in thyroid as compared with hypothalamo-pituitary sensitivity, and/or the effects of associations between the curves. The slope (−0.6) of the population curve in the normal range  is similar to the slope (−0.59) of the curve of physiological TSH studies , and therefore it would seem more likely that the slope there has been generated by the mechanism described in Figure 4(a), that is, the different degrees of variation in organ sensitivity.
We found that the increases in slope moving away from the edges of the normal T4 range  are consistent with adaptive shifts in the TSH curve in response to low and high T4 levels. The slope of the different individuals’ TSH response curves need not necessarily change. These shifts are consistent with thyrotroph hyperplasia and hypertrophy in primary hypothyroidism and thyrotroph atrophy and degeneration in hyperthyroidism [7, 17, 18] as well as other possible physiological changes [7, 10].
Therefore outside of the normal range because the TSH response curves are shifted vertically any points of intersection with the T4 response curves are also so shifted; that is, with progressive hypothyroidism/hyperthyroidism the points of intersection are on progressively changing TSH curves (Figure 6). Thus the population curve incorporates changes in organ sensitivity over time in response to ambient physiology whereas the physiological curves are based on studies that have been conducted over a relatively short period of time and therefore with stable organ sensitivities.
Though thyroid physiology and in particular the physiology of the control of thyroid hormones is complex, it can be simplified to this model based on the two physiological curves . Though T3, the active thyroid hormone , acting via the TRβ2 receptor, and not T4, is regarded as the regulator of TSH physiology and gene expression [20–22], and though there is also a negative log-linear relationship between T3 and TSH , Goede et al.  point out that the model does not require consideration of T3 levels. They state, “Using a model with two degrees of freedom allows the contributory factor exerted by [FT3] to be completely subsumed within the two structural parameters such that only [FT4] remains the stimulus variable connecting the [TSH] as the response.”
The pituitary, though ultimately responsive to T3, is more responsive to T3 generated in the pituitary from circulating T4 by type 2 deiodinase than to circulating T3, and TSH levels are more consistently related to levels of T4 than T3 [7, 23–25]. There are physiological advantages of this preference .
Various other components of thyroid physiology contribute to the derivation of, and are embedded in, the physiological curves, but as such, their detailed consideration is also not material to this discussion. Such components include deiodinases, hormone transporters, transcription factors, and other processes of thyroid hormone metabolism. All of these other processes of thyroid physiology influence the derivation of these two curves in any individual and thus the interindividual differences.
There has been confusion regarding the information to be derived from population studies of the T4/TSH set point. There are a few possible reasons for this. The similarity of the population curve and the TSH curve may have led researchers [4, 5, 7, 8] to believe that the two curves describe the same physiology. Differences between the curves have led to discussion as to which curve better describes this physiology [4, 5, 7–9].
The physiological studies of individuals show this inverse relationship between T4 and TSH because of the method of study; that is, in individuals the TSH was measured at different levels of T4 [1–3]. The other, equally important curve of measured T4 with different levels of TSH is more difficult to define empirically and perhaps on account of this, and perhaps because of the believed primacy of hypothalamo-pituitary function , there has been no discussion in the above literature as to why the population curve does or does not resemble the T4 curve.
The fact that the population graph has a negative slope reminiscent of the TSH curve can most simply be accounted for by a greater population variation in thyroid sensitivity to TSH as compared with pituitary sensitivity to T4. Outside of the normal range the relationship is consistent with the greater preponderance of primary as distinct from secondary thyroid dysfunction [7, 27, 28]. This phenomenon has been exaggerated by the methodology of the population studies whereby those individuals with a suggestion of pituitary dysfunction were excluded [4, 5, 10]. A less parsimonious explanation might invoke associations between the two physiological curves. Still however the population curve would reflect the pattern of interindividual variation in the T4 and TSH curves.
Our results are robust as to the shape of the physiological curves and were identical when we considered different formulas for the different curves [2, 4, 5, 29]. Similarly our results do not depend upon the nature of variation in the physiological curves (e.g., the different TSH curves need not be parallel). Our results will apply so long as there is, as is implied by the feedback loop physiology, a physiologic range whereby T4 levels increase in response to increasing TSH levels and TSH levels decrease in response to increasing T4 levels.
Leow  has indicated that each individual on the population curve may have a TSH curve consistent with a log-linear relationship and that the TSH curve may vary in different functional states. Midgley et al.  have also discussed differing physiology in the various thyroid states contributing to the various slopes of different segments of the population curve. These authors do not however demonstrate that the slope of the population curve is dependent on how the variation of the T4 curve compares with the variation of the TSH curve and that this slope is subject to modulation by adaptive changes to the TSH curve in the hyper- and hypothyroid ranges.
Our findings regarding the population curve in the hypo- and hyperthyroid ranges extend previous work. Such studies of the TSH curve have indeed shown similarly straight curves for hypothyroid [1, 2] and euthyroid  individuals. The shift between them has been attributed to the treatment of hypothyroidism with T4 and a consequent relative deficiency of T3 . This in turn was interpreted as demonstrating that T3 provides the dominant control over TSH levels even though the study itself was not entirely consistent with this proposition and despite other studies  (confirmed since ) that there is not a good relationship between T3 and TSH levels. Furthermore one of the recent population studies showed that the relationship between T4 and TSH appeared to be similar in subjects receiving thyroxine therapy and untreated individuals at steady euthyroid state . All of this data is consistent with T4 being the dominant controller of TSH levels , and the shift in the TSH curve in hypothyroid individuals being rather the result of the physiological changes to the pituitary and hypothalamus in hypothyroidism. The population curve, relying on the intersection of the T4 curves with these shifted TSH curves, is consistent with the effects of these changes.
Other aspects of physiology , pathophysiology  and technical factors regarding the assays  might also influence the population curve and its scatter. The changes in the population curve depending on age and sex  are also explicable by changes related to age and sex to the two physiological curves [32, 33].
Our proposed relationship between the population curve and the T4 and TSH curves is amenable to further study and disproof. The contributions of variations in organ sensitivity, physiological associations, hypertrophy, atrophy, and so forth could be elucidated, for example, by mapping the individual physiological curves contributing to individual population points and by studying in humans or animals any change in the physiological curves over time in response to changes in T4 levels. The difficulty in mapping T4 curves presents a technical challenge.
In summary, this work offers a resynthesis of the empiric data concerning the T4/TSH relationship, demonstrating that the previously derived individual physiological data and population set point data refer to different relationships, which are compatible with each other, and that therefore the former needs no revision on account of the latter. The similarities and differences previously noted are readily explained by population variations in physiology and by the known physiological responses to primary thyroid dysfunction. In turn the population data imply a particular pattern of interindividual variation of thyroid and pituitary physiology. This clarification and simplification of the T4/TSH relationship, apart from having intrinsic value, may contribute to the further understanding of thyroid physiology and in particular the understanding of thyroid regulation.
The authors declare that they have no competing interests.
- L. H. Fish, H. L. Schwartz, J. Cavanaugh, M. W. Steffes, J. P. Bantle, and J. H. Oppenheimer, “Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: role of triiodothyronine in pituitary feedback in humans,” New England Journal of Medicine, vol. 316, no. 13, pp. 764–770, 1987.
- N. Benhadi, E. Fliers, T. J. Visser, J. B. Reitsma, and W. M. Wiersinga, “Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers,” European Journal of Endocrinology, vol. 162, no. 2, pp. 323–329, 2010.
- S. Reichlin and R. D. Utiger, “Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma,” Journal of Clinical Endocrinology and Metabolism, vol. 27, no. 2, pp. 251–255, 1967.
- N. C. Hadlow, K. M. Rothacker, R. Wardrop, S. J. Brown, E. M. Lim, and J. P. Walsh, “The relationship between TSH and free T4 in a large population is complex and nonlinear and differs by age and sex,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 7, pp. 2936–2943, 2013.
- R. Hoermann, W. Eckl, C. Hoermann, and R. Larisch, “Complex relationship between free thyroxine and TSH in the regulation of thyroid function,” European Journal of Endocrinology, vol. 162, no. 6, pp. 1123–1129, 2010.
- M. C. Eisenberg, F. Santini, A. Marsili, A. Pinchera, and J. J. Di Stefano III, “TSH regulation dynamics in central and extreme primary hypothyroidism,” Thyroid, vol. 20, no. 11, pp. 1215–1228, 2010.
- J. W. Dietrich, G. Landgrafe, and E. H. Fotiadou, “TSH and thyrotropic agonists: key actors in thyroid homeostasis,” Journal of Thyroid Research, vol. 2012, Article ID 351864, 29 pages, 2012.
- M. K.-S. Leow, “The TSH-free thyroxine relationship: logarithmic-linear or error function?” European Journal of Endocrinology, vol. 163, no. 5, pp. 839–840, 2010.
- P. Rodien, “No heresy, rather hysteresis. Reply to: the TSH-free thyroxine relationship: logarithmic-linear or error function?” European Journal of Endocrinology, vol. 163, p. 841, 2010.
- J. E. M. Midgley, R. Hoermann, R. Larisch, and J. W. Dietrich, “Physiological states and functional relation between thyrotropin and free thyroxine in thyroid health and disease: in vivo and in silico data suggest a hierarchical model,” Journal of Clinical Pathology, vol. 66, no. 4, pp. 335–342, 2013.
- C. H. Emerson and M. S. T. Torres, “Recombinant human thyroid-stimulating hormone: pharmacology, clinical applications and potential uses,” BioDrugs, vol. 17, no. 1, pp. 19–38, 2003.
- L. Ramirez, L. E. Braverman, B. White, and C. H. Emerson, “Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 9, pp. 2836–2839, 1997.
- M. S. T. Torres, L. Ramirez, P. H. Simkin, L. E. Braverman, and C. H. Emerson, “Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1660–1664, 2001.
- S. Norlela, K. N. Azml, and B. A. K. Khalid, “Pituitary thyroid resistance syndrome,” Medical Journal of Malaysia, vol. 60, no. 5, pp. 642–643, 2005.
- D. J. Birkett, “Pharmacodynamics-the concentration-effect relationship,” Australian Prescriber, vol. 18, no. 4, pp. 102–104, 1995.
- S. L. Goede, M. K.-S. Leow, J. W. A. Smit, and J. W. Dietrich, “A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applications,” Mathematical Biosciences, vol. 249, no. 1, pp. 1–7, 2014.
- A. M. Alkhani, M. Cusimano, K. Kovacs, J. M. Bilbao, E. Horvath, and W. Singer, “Cytology of pituitary thyrotroph hyperplasia in protracted primary hypothyroidism,” Pituitary, vol. 1, no. 3-4, pp. 291–295, 1999.
- A. I. Torres, H. A. Pasolli, C. A. Maldonado, and A. Aoki, “Changes in thyrotroph and somatotroph cell populations induced by stimulation and inhibition of their secretory activity,” The Histochemical Journal, vol. 27, no. 5, pp. 370–379, 1995.
- S. M. Abdalla and A. C. Bianco, “Defending plasma T3 is a biological priority,” Clinical Endocrinology, vol. 81, no. 5, pp. 633–641, 2014.
- E. D. Abel, R. S. Ahima, M.-E. Boers, J. K. Elmquist, and F. E. Wondisford, “Critical role for thyroid hormone receptor β2 in the regulation of paraventricular thyrotropin-releasing hormone neurons,” The Journal of Clinical Investigation, vol. 107, no. 8, pp. 1017–1023, 2001.
- R. G. Cheron, M. M. Kaplan, and P. R. Larsen, “Physiological and pharmacological influences on thyroxine to 3,5,3′-triiodothyronine conversion and nuclear 3,5,3′-triiodothyronine binding in rat anterior pituitary,” The Journal of Clinical Investigation, vol. 64, no. 5, pp. 1402–1414, 1979.
- M. A. Shupnik, L. J. Ardisson, and M. J. Meskell, “Triiodothyronine (T3) regulation of thyrotropin subunit gene transcription is proportional to T3 nuclear receptor occupancy,” Endocrinology, vol. 118, no. 1, pp. 367–371, 1986.
- R. Mansoor, S. S. R. Rizvi, W. Kausar, F. Aslam, and S. T. Huda, “Comparison of TSH, T4 and T3 levels in primary hypothyroidism in relation to gender and age in a tertiary care hospital,” Annals of Pakistan Institute of Medical Sciences, vol. 7, no. 4, pp. 186–190, 2011.
- I. J. Chopra, J. M. Hershman, and R. W. Hornabrook, “Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea,” Journal of Clinical Endocrinology and Metabolism, vol. 40, no. 2, pp. 326–333, 1975.
- P. R. Larsen, “Thyroid-pituitary interaction—feedback regulation of thyrotropin secretion by thyroid hormones,” The New England Journal of Medicine, vol. 306, no. 1, pp. 23–32, 1982.
- E. Fliers, A. Kalsbeek, and A. Boelen, “Mechanisms in endocrinology: beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis,” European Journal of Endocrinology, vol. 171, no. 5, pp. R197–R208, 2014.
- M. P. J. Vanderpump, “The epidemiology of thyroid disease,” British Medical Bulletin, vol. 99, no. 1, pp. 39–51, 2011.
- A. Staii, S. Mirocha, K. Todorova-Koteva, S. Glinberg, and J. C. Jaume, “Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state,” Thyroid Research, vol. 3, no. 1, p. 11, 2010.
- M. K.-S. Leow and S. L. Goede, “The homeostatic set point of the hypothalamus-pituitary-thyroid axis—maximum curvature theory for personalized euthyroid targets,” Theoretical Biology and Medical Modelling, vol. 11, article 35, 2014.
- M. F. Prummel, L. J. S. Brokken, and W. M. Wiersinga, “Ultra short-loop feedback control of thyrotropin secretion,” Thyroid, vol. 14, no. 10, pp. 825–829, 2004.
- C. A. Spencer, “Thyroid profiling for the 1990's: free T4 estimate or sensitive TSH measurement,” Journal of Clinical Immunoassay, vol. 12, pp. 82–89, 1989.
- J. Ehrenkranz, P. R. Bach, G. L. Snow et al., “Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex,” Thyroid, vol. 25, no. 8, pp. 954–961, 2015.
- S. A. D'Angelo, “Simultaneous effects of estradiol on TSH secretion and adrenocortical function in male and female rats,” Endocrinology, vol. 82, no. 5, pp. 1035–1041, 1968.
- B. Pandiyan, S. J. Merrill, and S. Benvenga, “A patient-specific model of the negative-feedback control of the hypothalamus-pituitary-thyroid (HPT) axis in autoimmune (Hashimoto's) thyroiditis,” Mathematical Medicine and Biology, vol. 31, no. 3, pp. 226–258, 2014.
- M. Eisenberg, M. Samuels, and J. J. Distefano III, “Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis,” Thyroid, vol. 18, no. 10, pp. 1071–1085, 2008.
Copyright © 2016 Stephen Paul Fitzgerald and Nigel Geoffrey Bean. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.